EpiBone

EpiBone is a biomedical engineering company that is developing technology to create bone tissue from a patient's mesenchymal stem cells in vitro for use in bone grafts.

History

EpiBone was founded in 2013 by Nina Tandon and Sarindr “Ik” Bhumiratana in New York City. The company’s technology derives from research in bone and osteochondral tissue engineering at Columbia University.^{[failed verification]}

References

↑ "This Woman's Revolutionary Startup Could Change 900,000 Surgeries A Year". Business Insider. Retrieved 2015-10-20.
↑ "EpiBone". Retrieved 2022-04-07.
↑ "This Startup Wants People to Grow Their Own Bone Transplants". Bloomberg.com. Archived from the original on 2022-12-03. Retrieved 2025-09-07.
↑ Murphy, Sean V.; Atala, Anthony (2016). Regenerative Medicine Technology: On-a-Chip Applications for Disease Modeling, Drug Discovery and Personalized Medicine. CRC Press. p. 407. ISBN 9781498711920.

This article about biomedical engineering is a stub. You can help Wikipedia by adding missing information.

This article about a corporation or company specializing in health technology is a stub. You can help Wikipedia by adding missing information.

[1] "This Woman's Revolutionary Startup Could Change 900,000 Surgeries A Year". Business Insider. Retrieved 2015-10-20.

[2] "EpiBone". Retrieved 2022-04-07.

[3] "This Startup Wants People to Grow Their Own Bone Transplants". Bloomberg.com. Archived from the original on 2022-12-03. Retrieved 2025-09-07.

[4] Murphy, Sean V.; Atala, Anthony (2016). Regenerative Medicine Technology: On-a-Chip Applications for Disease Modeling, Drug Discovery and Personalized Medicine. CRC Press. p. 407. ISBN 9781498711920.

EpiBone

History

See also

References